Literature DB >> 23385354

A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin's lymphoma patient.

Chunchen Wu, Hui Shi, Mengji Lu, Yang Xu, Xinwen Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385354      PMCID: PMC8208410          DOI: 10.1007/s12250-013-3285-x

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  22 in total

1.  Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.

Authors:  B Moerman; V Moons; H Sommer; Y Schmitt; M Stetter
Journal:  Clin Lab       Date:  2004       Impact factor: 1.138

2.  Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.

Authors:  Michiko Yamagata; Toshimitsu Murohisa; Kohei Tsuchida; Yutaka Okamoto; Saburo Tsunoda; Masae Nakamura; Koji Kusano; Yuichi Majima; Toru Kuniyoshi; Makoto Iijima; Hitoshi Sugaya; Hideyuki Hiraishi
Journal:  Leuk Lymphoma       Date:  2007-02

3.  Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.

Authors:  Toshiki Sera; Yoichi Hiasa; Kojiro Michitaka; Ichiro Konishi; Kana Matsuura; Yoshio Tokumoto; Bunzo Matsuura; Takeshi Kajiwara; Toshikazu Masumoto; Norio Horiike; Morikazu Onji
Journal:  Intern Med       Date:  2006-07-03       Impact factor: 1.271

4.  Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.

Authors:  Kosei Matsue; Shun-ichi Kimura; Yoko Takanashi; Kan-ichi Iwama; Hideaki Fujiwara; Masayuki Yamakura; Masami Takeuchi
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs.

Authors:  Debra D Dahlen; Virginia C Broudy; Jonathan G Drachman
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

6.  Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.

Authors:  Alexandra Alexopoulou; Spyros P Dourakis; Helen Pandelidaki; Athanasios J Archimandritis; Peter Karayiannis
Journal:  J Med Virol       Date:  2006-08       Impact factor: 2.327

7.  Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.

Authors:  Ji-Ming Zhang; Yang Xu; Xin-Yu Wang; You-Kuan Yin; Xiang-Hui Wu; Xin-Hua Weng; Mengji Lu
Journal:  Clin Infect Dis       Date:  2007-03-19       Impact factor: 9.079

8.  Hepatitis B virus reactivation and alemtuzumab therapy.

Authors:  Emilio Iannitto; Viviana Minardi; Giuseppina Calvaruso; Antonino Mulè; Emanuele Ammatuna; Rosa Di Trapani; Rosa D Trapani; Donatella Ferraro; Vincenzo Abbadessa; Antonio Craxí; Rosa Di Stefano; Rosa D Stefano
Journal:  Eur J Haematol       Date:  2005-03       Impact factor: 2.997

9.  Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Authors:  Winnie Yeo; Tung C Chan; Nancy W Y Leung; Wai Y Lam; Frankie K F Mo; Miu Ting Chu; Henry L Y Chan; Edwin P Hui; Kenny I K Lei; Tony S K Mok; Paul K S Chan
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

10.  A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy.

Authors:  Chunchen Wu; Hui Shi; Yun Wang; Mengji Lu; Yang Xu; Xinwen Chen
Journal:  Virol Sin       Date:  2012-11-09       Impact factor: 4.327

View more
  2 in total

Review 1.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.

Authors:  Chien-Yuan Chen; Sheng-Yi Huang; Aristine Cheng; Wen-Chien Chou; Ming Yao; Jih-Luh Tang; Woei Tsay; Wang-Huei Sheng; Hwei-Fang Tien
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.